Literature DB >> 28833094

Progress and prospects of circular RNAs in Hepatocellular carcinoma: Novel insights into their function.

Ji Hu1,2, Peng Li3, Yang Song4, Yun-Xuan Ge5, Xiao-Ming Meng1,2, Cheng Huang1,2, Jun Li1,2, Tao Xu1,2.   

Abstract

Hepatocellular carcinoma (HCC) is one of the most predominant subjects of liver malignancies, which arouses global concern in the recent years. Advanced studies have found that Circular RNAs (circRNAs) are differentially expressed in HCC, with its regulatory capacity in HCC pathogenesis and metastasis. However, the underlying mechanism remains largely unknown. In this review, we summarized the functions and mechanisms of those aberrantly expressed circRNAs in HCC tissues. We hope to enlighten more comprehensive studies on the detailed mechanisms of circRNAs and explore their potential values in clinic applications. It revealed that hsa_circ_0004018 can be used as a potential biomarker in HCC diagnosis, with its superior sensitivity to alpha-fetoprotein (AFP). Notably, the correlation of circRNA abundance in the proliferation of liver regeneration (LR) has recently been clarified and different circRNA profiles served as candidates for nonalcoholic steatohepatitis (NASH) diagnosis also be discussed. Therefore, the improved understanding of circRNAs in HCC pathogenesis and metastasis proposed a novel basis for the early diagnosis in HCC patients, which provides a useful resource to explore the pathogenesis of HCC.
© 2017 Wiley Periodicals, Inc.

Entities:  

Keywords:  HCC; biomarker; circular RNAs; liver; microRNA

Mesh:

Substances:

Year:  2017        PMID: 28833094     DOI: 10.1002/jcp.26154

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  26 in total

1.  Hsa_circ_0103809 promotes cell proliferation and inhibits apoptosis in hepatocellular carcinoma by targeting miR-490-5p/SOX2 signaling pathway.

Authors:  Huajie Cai; Bingren Hu; Ling Ji; Xiaojiao Ruan; Zhihai Zheng
Journal:  Am J Transl Res       Date:  2018-06-15       Impact factor: 4.060

2.  Circular RNA circUBE2D2 functions as an oncogenic factor in hepatocellular carcinoma sorafenib resistance and glycolysis.

Authors:  Hai Huang; Jian Peng; Shijian Yi; Chengmin Ding; Wei Ji; Qiangsong Huang; Suna Zeng
Journal:  Am J Transl Res       Date:  2021-06-15       Impact factor: 4.060

3.  Prognostic Values of BolA Family Member Expression in Hepatocellular Carcinoma.

Authors:  Dong Wang; ZhiMing Wang; YiMing Tao
Journal:  Biomed Res Int       Date:  2022-08-16       Impact factor: 3.246

Review 4.  Novel Insight of CircRNAs in Cervical Cancer: Potential Biomarkers and Therapeutic Target.

Authors:  Maomao Wu; Yanxun Han; Xiangfei Gong; Ke Wan; Yuchen Liu; Yi Zhou; Lizhi Zhang; Guozheng Tang; Hui Fang; Bangjie Chen; Fan Yang; Qing Zhao; Genbao Wang; Chenghao Zhanghuang; Yunling Zhang
Journal:  Front Med (Lausanne)       Date:  2022-06-23

5.  Circular RNA expression and circPTPRM promotes proliferation and migration in hepatocellular carcinoma.

Authors:  Zhun Luo; Xuelan Mao; Wei Cui
Journal:  Med Oncol       Date:  2019-09-07       Impact factor: 3.064

6.  Circ_0004018 suppresses cell proliferation and migration in hepatocellular carcinoma via miR-1197/PTEN/PI3K/AKT signaling pathway.

Authors:  He Wang; Qiao Zhang; Wenyu Cui; Wenlan Li; Jimei Zhang
Journal:  Cell Cycle       Date:  2021-09-27       Impact factor: 5.173

7.  CircRNAs as biomarkers of cancer: a meta-analysis.

Authors:  Miao Wang; Yuxi Yang; Jian Xu; Wen Bai; Xueli Ren; Huijian Wu
Journal:  BMC Cancer       Date:  2018-03-20       Impact factor: 4.430

8.  hsa_circ_0004018 suppresses the progression of liver fibrosis through regulating the hsa-miR-660-3p/TEP1 axis.

Authors:  Shan Li; Fangmin Song; Xu Lei; Jingtao Li; Fang Li; Huabing Tan
Journal:  Aging (Albany NY)       Date:  2020-06-25       Impact factor: 5.682

Review 9.  The novel roles of circular RNAs in metabolic organs.

Authors:  Zhi-Chun Zhang; Xiao-Long Guo; Xi Li
Journal:  Genes Dis       Date:  2017-12-18

10.  Piplartine attenuates the proliferation of hepatocellular carcinoma cells via regulating hsa_circ_100338 expression.

Authors:  Xiaoli Cheng; Pan Tian; Wengzhong Zheng; Xuetao Yan
Journal:  Cancer Med       Date:  2020-04-13       Impact factor: 4.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.